 Hala Nijmeh
Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasa Vasorum | 4 | 2023 | 36 | 0.810 |
Why?
| | Neovascularization, Pathologic | 3 | 2020 | 285 | 0.530 |
Why?
| | Pulmonary Artery | 4 | 2023 | 1116 | 0.370 |
Why?
| | Hypertension, Pulmonary | 2 | 2020 | 1957 | 0.250 |
Why?
| | Hypoxia | 1 | 2014 | 1209 | 0.230 |
Why?
| | Receptors, Purinergic P2Y | 2 | 2020 | 9 | 0.200 |
Why?
| | Adventitia | 1 | 2023 | 42 | 0.180 |
Why?
| | Brain Stem Neoplasms | 1 | 2023 | 86 | 0.180 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2022 | 333 | 0.170 |
Why?
| | Carbazoles | 1 | 2021 | 53 | 0.170 |
Why?
| | Lung Neoplasms | 3 | 2022 | 2674 | 0.160 |
Why?
| | Trastuzumab | 1 | 2021 | 119 | 0.160 |
Why?
| | Protein-Tyrosine Kinases | 3 | 2022 | 429 | 0.160 |
Why?
| | Endothelial Cells | 3 | 2023 | 876 | 0.160 |
Why?
| | Forkhead Box Protein O3 | 1 | 2020 | 18 | 0.150 |
Why?
| | Endothelium | 1 | 2020 | 119 | 0.150 |
Why?
| | Piperidines | 1 | 2021 | 223 | 0.150 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 153 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2022 | 889 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 2 | 2022 | 615 | 0.140 |
Why?
| | Cattle | 3 | 2023 | 938 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2020 | 157 | 0.140 |
Why?
| | Gene Fusion | 1 | 2018 | 30 | 0.140 |
Why?
| | Glioma | 1 | 2023 | 425 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 2 | 2022 | 982 | 0.140 |
Why?
| | Bronchi | 2 | 2011 | 263 | 0.130 |
Why?
| | Wound Healing | 2 | 2011 | 348 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 538 | 0.110 |
Why?
| | Cell Migration Assays | 1 | 2014 | 4 | 0.100 |
Why?
| | Colony-Forming Units Assay | 1 | 2014 | 95 | 0.100 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 49 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2014 | 73 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1194 | 0.100 |
Why?
| | Epithelial Cells | 2 | 2011 | 1118 | 0.090 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 1 | 2011 | 15 | 0.090 |
Why?
| | Telomerase | 1 | 2014 | 252 | 0.080 |
Why?
| | Signal Transduction | 3 | 2020 | 5234 | 0.080 |
Why?
| | Animals, Newborn | 1 | 2014 | 887 | 0.080 |
Why?
| | Receptors, Purinergic P2Y1 | 1 | 2010 | 8 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2014 | 2497 | 0.080 |
Why?
| | Antigens, CD | 1 | 2014 | 559 | 0.080 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2008 | 43 | 0.070 |
Why?
| | Calcium Signaling | 1 | 2010 | 246 | 0.070 |
Why?
| | Genes, Tumor Suppressor | 1 | 2008 | 84 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2218 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 456 | 0.060 |
Why?
| | Calcium | 1 | 2010 | 1181 | 0.050 |
Why?
| | Dexamethasone | 1 | 2006 | 368 | 0.050 |
Why?
| | Endothelium, Vascular | 1 | 2010 | 952 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2020 | 438 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 2023 | 38 | 0.050 |
Why?
| | Animals | 5 | 2023 | 38030 | 0.050 |
Why?
| | Cytidine Deaminase | 1 | 2023 | 59 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1429 | 0.050 |
Why?
| | Brain Stem | 1 | 2023 | 101 | 0.040 |
Why?
| | Gene Amplification | 1 | 2022 | 116 | 0.040 |
Why?
| | Asthma | 2 | 2011 | 1800 | 0.040 |
Why?
| | Indazoles | 1 | 2022 | 86 | 0.040 |
Why?
| | Biology | 1 | 2023 | 90 | 0.040 |
Why?
| | Benzamides | 1 | 2022 | 226 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 2008 | 927 | 0.040 |
Why?
| | Maximum Tolerated Dose | 1 | 2021 | 216 | 0.040 |
Why?
| | Cells, Cultured | 3 | 2011 | 4112 | 0.030 |
Why?
| | Survival Analysis | 1 | 2021 | 1372 | 0.030 |
Why?
| | Vascular Remodeling | 1 | 2020 | 208 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2020 | 384 | 0.030 |
Why?
| | Humans | 10 | 2023 | 145625 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 494 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2022 | 1062 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2021 | 2018 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 454 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2020 | 1367 | 0.020 |
Why?
| | Male | 3 | 2018 | 73014 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 5397 | 0.020 |
Why?
| | Mutation | 1 | 2022 | 4082 | 0.020 |
Why?
| | Purinergic Agonists | 1 | 2010 | 4 | 0.020 |
Why?
| | Ribosomal Protein S6 | 1 | 2010 | 18 | 0.020 |
Why?
| | Pertussis Toxin | 1 | 2010 | 24 | 0.020 |
Why?
| | Pyridoxal Phosphate | 1 | 2010 | 20 | 0.020 |
Why?
| | Receptors, Purinergic | 1 | 2010 | 20 | 0.020 |
Why?
| | Alveolar Epithelial Cells | 1 | 2011 | 121 | 0.020 |
Why?
| | Azo Compounds | 1 | 2010 | 30 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 2010 | 75 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 133 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1041 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 169 | 0.020 |
Why?
| | Calcium Channels | 1 | 2010 | 157 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2008 | 20 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2915 | 0.020 |
Why?
| | Loss of Heterozygosity | 1 | 2008 | 51 | 0.020 |
Why?
| | Genes, ras | 1 | 2008 | 70 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 840 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2008 | 290 | 0.020 |
Why?
| | Gene Silencing | 1 | 2008 | 200 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 6045 | 0.020 |
Why?
| | Gene Deletion | 1 | 2008 | 384 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2008 | 385 | 0.010 |
Why?
| | Hyaluronan Receptors | 1 | 2006 | 105 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1236 | 0.010 |
Why?
| | DNA Methylation | 1 | 2008 | 721 | 0.010 |
Why?
| | ErbB Receptors | 1 | 2006 | 636 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2006 | 536 | 0.010 |
Why?
| | Cell Movement | 1 | 2006 | 950 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 3538 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 4329 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 2455 | 0.010 |
Why?
| | Models, Biological | 1 | 2006 | 1758 | 0.010 |
Why?
| | Mice | 1 | 2008 | 18266 | 0.010 |
Why?
| | Female | 1 | 2018 | 79080 | 0.000 |
Why?
|
|
Nijmeh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|